CIK 0001237831
- Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043744954
- Phone
- +1 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,794,049
- in 3 filings, $425K under 10b5-1 plans
Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 40 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | RHOADS ANN D Director | Sale 10b5-1 | −5,000 | $85.00 | $425K | 35,384 |
| 2026-06-04 | RHOADS ANN D Director | Exercise or conversion | +25,000 | $26.27 | $657K | 40,384 |
| 2026-06-04 | RHOADS ANN D Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −25,000 | 0 | ||
| 2026-01-21 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2025-11-10 | RHOADS ANN D Director | Sale 10b5-1 | −2,000 | $85.00 | $170K | 15,384 |
| 2025-11-07 | RHOADS ANN D Director | Sale 10b5-1 | −8,000 | $81.00 | $648K | 17,384 |
| 2025-09-15 | RHOADS ANN D Director | Sale 10b5-1 | −10,000 | $58.46 | $585K | 25,384 |
| 2025-02-28 | RHOADS ANN D Director | Sale 10b5-1 | −7,500 | $78.68 | $590K | 35,384 |
| 2025-01-23 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-09-13 | RHOADS ANN D Director | Exercise or conversion | +15,000 | $24.10 | $362K | 37,884 |
| 2024-09-13 | RHOADS ANN D Director | Exercise or conversion | +20,000 | $25.52 | $510K | 57,884 |
| 2024-09-13 | RHOADS ANN D Director | Sale | −15,000 | $70.36 | $1.1M | 42,884 |
| 2024-09-13 | RHOADS ANN D Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −15,000 | 0 | ||
| 2024-09-13 | RHOADS ANN D Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −20,000 | 0 | ||
| 2024-01-26 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2023-01-27 | RHOADS ANN D Director | Exercise or conversion | +7,500 | $12.59 | $94K | 22,884 |
| 2023-01-27 | RHOADS ANN D Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −7,500 | 0 | ||
| 2023-01-26 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2022-01-27 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2021-03-01 | RHOADS ANN D Director | Exercise or conversion | +15,384 | $10.66 | $164K | 15,384 |
Page 1 of 2 · 30 trades